News for SMALL PHARMA INC (DMT.V)

Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) released its financial results for second quarter ended September 30, 2023.

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted

Ryu Apparel Shifts Listing To Nex Amid Non-Compliance Issues

Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement.

Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international clinical-stage leader in psychedelic-based...

Short-acting psychedelics biotech Small Pharma Inc.

Small Pharma Inc. , a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. , a clinical-stage biopharmaceutical company...